Microbiology

  1. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

    1. Fabian Schmidt
    2. Yiska Weisblum
    3. Frauke Muecksch
    4. Hans-Heinrich Hoffmann
    5. Eleftherios Michailidis
    6. Julio C.C. Lorenzi
    7. Pilar Mendoza
    8. Magdalena Rutkowska
    9. Eva Bednarski
    10. Christian Gaebler
    11. Marianna Agudelo
    12. Alice Cho
    13. Zijun Wang
    14. Anna Gazumyan
    15. Melissa Cipolla
    16. Marina Caskey
    17. Davide F. Robbiani
    18. Michel C. Nussenzweig
    19. Charles M. Rice
    20. Theodora Hatziioannou
    21. Paul D. Bieniasz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Insight into Vaccine Development for Alphacoronaviruses Based on Structural and Immunological Analyses of Spike Proteins

    1. Yuejun Shi
    2. Jiale Shi
    3. Limeng Sun
    4. Yubei Tan
    5. Gang Wang
    6. Fenglin Guo
    7. Guangli Hu
    8. Yanan Fu
    9. Zhen F. Fu
    10. Shaobo Xiao
    11. Guiqing Peng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

    1. Ruochen Zang
    2. James Brett Case
    3. Eylan Yutuc
    4. Xiucui Ma
    5. Sheng Shen
    6. Maria Florencia Gomez Castro
    7. Zhuoming Liu
    8. Qiru Zeng
    9. Haiyan Zhao
    10. Juhee Son
    11. Paul W. Rothlauf
    12. Alex J. B. Kreutzberger
    13. Gaopeng Hou
    14. Hu Zhang
    15. Sayantan Bose
    16. Xin Wang
    17. Michael D. Vahey
    18. Kartik Mani
    19. William J. Griffiths
    20. Tom Kirchhausen
    21. Daved H. Fremont
    22. Haitao Guo
    23. Abhinav Diwan
    24. Yuqin Wang
    25. Michael S. Diamond
    26. Sean P. J. Whelan
    27. Siyuan Ding

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Structural basis of a shared antibody response to SARS-CoV-2

    1. Meng Yuan
    2. Hejun Liu
    3. Nicholas C. Wu
    4. Chang-Chun D. Lee
    5. Xueyong Zhu
    6. Fangzhu Zhao
    7. Deli Huang
    8. Wenli Yu
    9. Yuanzi Hua
    10. Henry Tien
    11. Thomas F. Rogers
    12. Elise Landais
    13. Devin Sok
    14. Joseph G. Jardine
    15. Dennis R. Burton
    16. Ian A. Wilson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

    1. Ritesh Tandon
    2. Joshua S. Sharp
    3. Fuming Zhang
    4. Vitor H. Pomin
    5. Nicole M. Ashpole
    6. Dipanwita Mitra
    7. Martin G. McCandless
    8. Weihua Jin
    9. Hao Liu
    10. Poonam Sharma
    11. Robert J. Linhardt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike

    1. Jérémie Prévost
    2. Romain Gasser
    3. Guillaume Beaudoin-Bussières
    4. Jonathan Richard
    5. Ralf Duerr
    6. Annemarie Laumaea
    7. Sai Priya Anand
    8. Guillaume Goyette
    9. Mehdi Benlarbi
    10. Shilei Ding
    11. Halima Medjahed
    12. Antoine Lewin
    13. Josée Perreault
    14. Tony Tremblay
    15. Gabrielle Gendron-Lepage
    16. Nicolas Gauthier
    17. Marc Carrier
    18. Diane Marcoux
    19. Alain Piché
    20. Myriam Lavoie
    21. Alexandre Benoit
    22. Vilayvong Loungnarath
    23. Gino Brochu
    24. Elie Haddad
    25. Hannah D. Stacey
    26. Matthew S. Miller
    27. Marc Desforges
    28. Pierre J. Talbot
    29. Graham T. Gould Maule
    30. Marceline Côté
    31. Christian Therrien
    32. Bouchra Serhir
    33. Renée Bazin
    34. Michel Roger
    35. Andrés Finzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Rapid inactivation of SARS-CoV-2 with Deep-UV LED irradiation

    1. Hiroko Inagaki
    2. Akatsuki Saito
    3. Hironobu Sugiyama
    4. Tamaki Okabayashi
    5. Shouichi Fujimoto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype

    1. Shubham Gaurav
    2. Shambhavi Pandey
    3. Apurvasinh Puvar
    4. Tejas Shah
    5. Madhvi Joshi
    6. Chaitanya Joshi
    7. Sachin Kumar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type

    1. Paul R. Lephart
    2. Michael A. Bachman
    3. William LeBar
    4. Scott McClellan
    5. Karen Barron
    6. Lee Schroeder
    7. Duane W. Newton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. An OpenData portal to share COVID-19 drug repurposing data in real time

    1. Kyle R. Brimacombe
    2. Tongan Zhao
    3. Richard T. Eastman
    4. Xin Hu
    5. Ke Wang
    6. Mark Backus
    7. Bolormaa Baljinnyam
    8. Catherine Z. Chen
    9. Lu Chen
    10. Tara Eicher
    11. Marc Ferrer
    12. Ying Fu
    13. Kirill Gorshkov
    14. Hui Guo
    15. Quinlin M. Hanson
    16. Zina Itkin
    17. Stephen C. Kales
    18. Carleen Klumpp-Thomas
    19. Emily M. Lee
    20. Sam Michael
    21. Tim Mierzwa
    22. Andrew Patt
    23. Manisha Pradhan
    24. Alex Renn
    25. Paul Shinn
    26. Jonathan H. Shrimp
    27. Amit Viraktamath
    28. Kelli M. Wilson
    29. Miao Xu
    30. Alexey V. Zakharov
    31. Wei Zhu
    32. Wei Zheng
    33. Anton Simeonov
    34. Ewy A. Mathé
    35. Donald C. Lo
    36. Matthew D. Hall
    37. Min Shen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 40 of 233 Next